Skip to main content

Avita seeks US market pre-approval

28/09/2017 - 14:28

Bookmark

Save articles for future reference.

Health technology company Avita Medical has submitted a pre-market approval application to the US Food and Drug Administration for its ReCell regenerative medicine technology.

X

To read our articles you will need to either login or subscribe.